explore -WSS

explore

author：hotspot 2025-10-01 11:20:06 - browse：72

The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

Acelyrin’s share price fell more than 60% in after-hours trading Monday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Prosecutors seek bail revocation for FTX founder Sam Bankman

hotspot

WSS

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

EU moves toward latest gene techniques in food production to counter climate change, shortages

2 million sign

Pentagon will tighten controls on classified information after Discord leak

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Calls for Trump's election interference trial to be televised part of long debate

Wikipedia

explore

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Eat, drink, but be wary — 4 foods that interact with medications

Trump demands the U.S. pay no more for drugs than other countries … again

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

As demand for Covid shots wanes, Moderna seeks its next success

Rock icon Freddie Mercury pre

The cancer drug shortage isn’t new — and neither are the solutions

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Alkermes shareholders re

Calls for Trump's election interference trial to be televised part of long debate

hotspot

Special counsel alerts court to Trump’s social media post

Pentagon will tighten controls on classified information after Discord leak

Parkland mass shooting to be reenacted for lawsuit

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Medical mystery: When an infection after surgery isn’t what it seems

A bus careens into a gulch in southern Mexico, leaving 27 people dead

focus

knowledge

hotspot

Wikipedia